Skip to main content

Percutaneous coronary revascularisation: is it ever worth what it costs?

Publication ,  Journal Article
Mark, DB
Published in: Heart
October 2007

“How could percutaneous coronary intervention without the risks and morbidities of heart surgery not be of benefit to patients? Hard experience teaches that such attractive “pathophysiological” simplifications are unreliable guides to practice and paradoxically may lead to worse rather than better treatment decisions” See also article on page 1238 and viewpoint on page 1188

Duke Scholars

Published In

Heart

DOI

EISSN

1468-201X

Publication Date

October 2007

Volume

93

Issue

10

Start / End Page

1161 / 1163

Location

England

Related Subject Headings

  • Myocardial Revascularization
  • Myocardial Infarction
  • Humans
  • Cost-Benefit Analysis
  • Cardiovascular System & Hematology
  • Angioplasty, Balloon, Coronary
  • Angina Pectoris
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mark, D. B. (2007). Percutaneous coronary revascularisation: is it ever worth what it costs? Heart, 93(10), 1161–1163. https://doi.org/10.1136/hrt.2007.130401
Mark, Daniel B. “Percutaneous coronary revascularisation: is it ever worth what it costs?Heart 93, no. 10 (October 2007): 1161–63. https://doi.org/10.1136/hrt.2007.130401.
Mark, Daniel B. “Percutaneous coronary revascularisation: is it ever worth what it costs?Heart, vol. 93, no. 10, Oct. 2007, pp. 1161–63. Pubmed, doi:10.1136/hrt.2007.130401.

Published In

Heart

DOI

EISSN

1468-201X

Publication Date

October 2007

Volume

93

Issue

10

Start / End Page

1161 / 1163

Location

England

Related Subject Headings

  • Myocardial Revascularization
  • Myocardial Infarction
  • Humans
  • Cost-Benefit Analysis
  • Cardiovascular System & Hematology
  • Angioplasty, Balloon, Coronary
  • Angina Pectoris
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences